SION – sionna therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Sionna Therapeutics (SION) had its "buy" rating reaffirmed by UBS Group AG.
Sionna Therapeutics (SION) had its "buy" rating reaffirmed by Guggenheim.
Sionna Therapeutics (SION) had its "buy" rating reaffirmed by BTIG Research. They now have a $58.00 price target on the stock.
Sionna Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
Sionna Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
Form 144 Sionna Therapeutics, Filed by: Fitzpatrick Jennifer
Form S-8 Sionna Therapeutics,
Form S-3ASR Sionna Therapeutics,
Form 10-K Sionna Therapeutics, For: Dec 31
Form 8-K Sionna Therapeutics, For: Mar 02
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.